Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine vs sufentanil for postoperative nausea and vomiting after laparoscopic total hysterectomy
ChiCTR2500097470Phase 4Recruiting
- Sponsor
- Shihezi University School of Medicine
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain and postoperative nausea and vomiting (PONV) (4 arms), sponsored by Shihezi University School of Medicine. Primary endpoints: Postoperative nausea and vomiting incidence rate and Postoperative adverse reactions. Started Feb 2025; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500097470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097470.